The Department of Veterans Affairs says it will not conduct research into whether medical marijuana could help veterans suffering from post-traumatic stress disorder and chronic pain, as veterans groups are pushing for the use of the drug as an alternative to opioids and anti-depressants.
Tag Archives: Research
When California’s regulators scrambled to make rules for the state’s new legal market, one issue was near the top of their list: How to deal with pot’s pesticide problem.
OAKLAND, Calif., Jan. 2, 2017 /Weed Wire/ — The total economic output from legal cannabis will grow 150% from $16 billion in 2017 to $40 billion by 2021, according to the “US Legal Cannabis: Driving $40 Billion Economic Output” report released today by Arcview Market Research, in partnership with BDS Analytics.
Out of 131 applicants, only 20 South Carolina farmers have been selected to grow hemp for the state’s research pilot program.
More pregnant women seem to be using pot — sometimes to ease the nausea of morning sickness or heightened anxiety — and a new study suggests that this slight rise in marijuana use is most pronounced among those younger in age.
Virginia is wrapping up its second year of a research program that allows farmers to grow hemp, a crop long banned because of its association with marijuana.
The University of the Sciences this week became the latest academic player in Philly to announce it was getting into marijuana research.
Investors have been eager to enter the Canadian marijuana space as the country moves towards launching its recreational cannabis market next July.
Teen use of marijuana remains high and vaping appears to be one reason, a new U.S. survey shows.
OTTAWA, Ontario, Dec. 13, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that the company has signed an exclusive research and development (R&D) agreement with Constance Therapeutics.
OAKLAND, Calif., Dec. 6, 2017 /Weed Wire/ – Consumer spending on legal cannabis in North America is outpacing previous estimates, according to a new report out today from Arcview Market Research.
Alcohol sales fell by 15 percent following the introduction of medical marijuana laws in a number of states, according to a new working paper by researchers at the University of Connecticut and Georgia State University.
SEATTLE, Nov. 27, 2017 /Weed Wire/ — About 1 in 7 adult primary care patients visiting medical offices reported having used marijuana at least once in the past year, according to a study conducted by Kaiser Permanente researchers since Washington state legalized nonmedical cannabis use in 2014.
LOS ANGELES, Nov. 14, 2017 /Weed Wire/ — Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com, a fully integrated, active real estate investor for the cannabis sector and consultant for multiple cannabis brands today announced that the Company has agreed and entered into negotiations to purchase the surrounding nine-hundred (900) acres of its’ existing 80 acre Hemp planned research site in Pueblo, Colorado.
When Asi Naim, a severely autistic Israeli boy, started smacking his head against the wall and hurting himself in other ways, his parents tried every kind of psychiatric drug to calm him. Nothing worked. Then Asi entered a cannabis-based research program at Jerusalem’s Shaarei Zedek hospital.
NANAIMO, British Columbia, Nov. 8, 2017 /Weed Wire/ — Tilray, a GMP-certified global leader in medical cannabis research and production, today announced that the company has successfully exported live medical cannabis genetics from its flagship British Columbia, Canada facility to its European Union Campus in Cantanhede, Portugal.
People who buy medical marijuana online may not necessarily get exactly what they expect when their package arrives in the mail, new research suggests.
Over the years, there’s been a lot of back and forth on whether or not weed affects your sex drive. So is weed really bad for your sex life?
While the United States Drug Enforcement Agency’s marijuana research license isn’t awarded lightly, an Ohio-based organization was recently awarded a Schedule I Researcher license by the DEA to study the effects of marijuana.
A group of 10 U.S. House members is pushing the Trump administration to begin researching medical marijuana’s potential benefits for military veterans struggling to cope with war wounds.
Can marijuana make fish relax? That is the question that researchers hoped to answer in a recent study published in the journal Aquaculture Research.
Rep. Matt Gaetz has been in Congress for less than a year, but the Florida Congressman has already become one of the House’s foremost leaders working to reform federal marijuana policies. Just one problem: GOP leadership doesn’t seem especially interested in giving the issue a fair shake.
In a Senate Judiciary Committee hearing Wednesday morning, Senator Orrin Hatch made the case for medical marijuana. During the hearing Hatch questioned U.S. Attorney General Jeff Sessions about a path forward for marijuana research.
Legal pot sales rose a stunning 34% in 2016 to $6.7 billion across North America, according to Arcview Market Research. But with growth this rapid, there’s bound to be more than a few marijuana stock investments that will be left behind.
You could call it a true grassroots movement: petition circulators not trying to legalize hemp and marijuana, but to start up a new third Nebraska political party.
Sales of marijuana oil cartridges used for vaping soared 400 percent between 2015 and 2016. But is marijuana vaping a safe trend?
While Canada is planning to delay the roll out of recreational cannabis edibles for regulatory reasons, it may give stakeholders the added benefit of having extra time to master their formulations for what may become a booming market segment.
NEW YORK, Sept. 27, 2017 /Weed Wire/ — The Green Market Report (GMR) has partnered with Consumer Research Around Cannabis to release a series of research market snapshots called ‘Cannabis Freakonomics’ highlighting interesting findings on the spending habits and profiles of cannabis consumers.
As the Golden State readies for the rollout of recreational cannabis on Jan. 1, 2018, some are preparing for a windfall of revenue from California cannabis taxes and others are preparing to continue competing with the black market.
What is the difference between medical marijuana and recreational marijuana? Watch this video from Dr. Oz to find the answer to this question and others.
Is marijuana unhealthy? In this video, Mic. the Vegan reviews over 20 studies on the topic to determine which myths and claims about marijuana’s harms and benefits are valid.
On Sept. 21, 2017, the Tennessee medical cannabis task force, created by Lt. Gov. Randy McNally and State House Speaker Beth Harwell, met for the first time to discuss legalization.
PORTLAND, Ore., Sept. 20, 2017 /Weed Wire/ — An Oregon Health Authority (OHA) education campaign aimed at youth and young adults raised awareness among its target audience of the risks associated with marijuana use, an independent evaluation has found.
CHICAGO, Sept.18, 2017 /Weed Wire/ – A bipartisan group of senators led by Brian Schatz (D-Hawaii) has reintroduced the Marijuana Effective Studies Act of 2016 (MEDS Act), which will remove excessive regulatory barriers inhibiting researchers from obtaining marijuana plants to conduct studies assessing the drug’s medical effectiveness and safety.
Last November, California voters approved a ballot measure to legalize marijuana. Now, the state’s lawmakers are formally calling on the federal government to reclassify marijuana.
WASHINGTON, Sept. 14, 2017 /Weed Wire/ — Senator Cory Gardner (R-CO) introduced the Marijuana Effective Drug Study (MEDS) Act of 2017 to improve the process for conducting scientific research on marijuana as a safe and effective medical treatment.
WASHINGTON, Sept. 14, 2017 /Weed Wire/ — Senator Cory Gardner (R-CO) introduced the Marijuana Effective Drug Study (MEDS) Act of 2017 to improve the process for conducting scientific research on marijuana as a safe and effective medical treatment. The legislation’s lead sponsor was Senator Orrin Hatch (R-UT).
On Sept. 13, 2017, U.S. Sen. Orrin Hatch, R-Utah, introduced legislation to cut the bureaucratic red tape thwarting medical cannabis research so health care professionals can harness the medicinal properties of the plant to reduce the suffering of patients in need.
WASHINGTON, Sept. 13, 2017 /Weed Wire/ — Today, Senator Thom Tillis (R-NC) joined Senators Brian Schatz (D-HI), Orrin Hatch (R-UT), Cory Gardner (R-CO) and Chris Coons (D-DE) to introduce the Marijuana Effective Drug Studies (MEDS) Act of 2017, bipartisan legislation that would make it easier for researchers to study the medical effectiveness and safety of marijuana.
PERTH, Australia, Sept. 13, 2017 /Weed Wire/ — The Board of Zelda Therapeutics Ltd (ASX: ZLD, Zelda or the Company) is pleased to announce it is making significant progress with its research programme in Chile.
WASHINGTON, Sept. 13, 2017 /Weed Wire/ — Senator Orrin Hatch (R-UT), a member and former Chairman of both the Senate Judiciary Committee and the Senate Health, Education, Labor and Pensions Committee, will speak on the Senate floor today about medical marijuana research and the possible benefits of medical marijuana as an alternative to opioids. The speech will take place at 3:30 on the Senate floor.
WASHINGTON, Sept. 13, 2017 /Weed Wire/ — Today, Senator Orrin Hatch (R-UT) introduced the Marijuana Effective Drug Study Act of 2017, or MEDS Act, to improve the process for conducting scientific research on marijuana as a safe and effective medical treatment. In introducing this legislation, Senator Hatch was joined by Senator Schatz (D-HI) and cosponsors Senator Chris Coons (D-DE), Senator Cory Gardner (R-CO), and Senator Thom Tillis (R-NC).
On Sept. 7, 2017, Gov. Phil Scott signed Executive Order 15-17, officially launching the Vermont Marijuana Advisory Commission. The commission will explore several options concerning how to successfully legalize recreational marijuana in the state.
The “gateway theory,” the theory that cannabis use leads to the use of harder drugs, has been debunked once again by academia.
Governor Phil Scott today issued Executive Order 15-17, establishing the Governor’s Marijuana Advisory Commission, charged with recommending a comprehensive approach to addressing health, safety, regulatory and infrastructure needs when considering legalized marijuana use.
CANTANHEDE, Portugal, Sept. 7, 2017 /Weed Wire/ – Tilray, a global pioneer in medical cannabis research and production, announced plans today to invest up to €20 million in a European Union Campus (EU Campus) after receiving licenses from the Government of Portugal to import cannabis genetics and to cultivate cannabis for medical purposes.
Louisiana State University has selected its medical marijuana vendor and now LSU Health Shreveport is ready to prepare for Louisiana medical marijuana research.
NEW PALTZ, NY, Sept. 8, 2017 /Weed Wire/ — The Benjamin Center for Public Policy Initiatives at SUNY New Paltz has released its 18th discussion brief, “The Marijuana Gateway Fallacy.” The brief marshals extensive social science evidence to show that the idea that marijuana use is a “gateway” to the use of harder drugs is a myth.
Washington has one more statistic to support the legalization of recreational cannabis in the Evergreen State: Washington youth cannabis use hasn’t increased since the enactment of Initiative 502, the measure that legalized recreational cannabis in the state.
OTTAWA, Ontario, Aug. 31, 2017 /Weed Wire/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP) (OTCQB:TBPMF), today announced that it will benefit from the intellectual property (IP) created within the cannabis health research Chair (The Chair) from the University of New Brunswick (UNB).